Lipella Pharmaceuticals Inc. (LIPO) stock
LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.27KP/E –Yield –
Lipella Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Lipella Pharmaceuticals's revenue for the twelve months ending Sep 30, 2025 was $389.78K, down 19.4% year over year. For fiscal 2024 it was $536.36K, up 19.3% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $536.36K | +19.3% |
| FY2023 | Dec 31, 2023 | $449.62K | +144.2% |
| FY2022 | Dec 31, 2022 | $184.16K | -29.0% |
| FY2021 | Dec 31, 2021 | $259.35K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $86.73K | -36.4% |
| Q1 FY2025 | Mar 31, 2025 | $129.39K | -11.3% |
| Q4 FY2024 | Dec 31, 2024 | $173.67K | +43.7% |
| Q3 FY2024 | Sep 30, 2024 | $80.38K | -22.7% |
| Q2 FY2024 | Jun 30, 2024 | $136.43K | +27.9% |
| Q1 FY2024 | Mar 31, 2024 | $145.88K | +23.6% |
| Q4 FY2023 | Dec 31, 2023 | $120.84K | -20.0% |
| Q3 FY2023 | Sep 30, 2023 | $104.05K | – |
| Q2 FY2023 | Jun 30, 2023 | $106.68K | – |
| Q1 FY2023 | Mar 31, 2023 | $118.05K | +256.1% |
| Q4 FY2022 | Dec 31, 2022 | $151.01K | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | – |
| Q2 FY2022 | Jun 30, 2022 | $0 | – |
| Q1 FY2022 | Mar 31, 2022 | $33.15K | – |
See a number that looks wrong?